Postbiotic Interventions via Hydrocolloid-Enhanced Delivery for Modulating the Gut-Brain Axis in Psychiatric Disorders: A Dietary Strategy Review

There is increasing evidence that the gut-brain axis (GBAx)—the bidirectional communication network connecting the gastrointestinal tract and the central nervous system—is a vital component of mental health. Historically, probiotics and prebiotics have been recognized for their ability to restore microbial balance, but postbiotics (POS)—comprising non-viable microbial cells or their metabolic by-products are now being more closely examined as a more stable and safer alternative for utilization in research and therapy settings. Hydrocolloid encapsulation emerges as a dietary strategy for stable POS delivery. This review consolidates the current understanding of POS interventions in the regulation of crucial components of GBAx, such as neuroinflammation, neurotransmitter synthesis, immune system, and epigenetic processes; all of which are pertinent to various psychiatric disorders e.g, depression, anxiety, autism spectrum disorder, bipolar disorder, and schizophrenia. Clinical trials have demonstrated that POSs can diminish symptom severity by regulating the immune pathways, balancing cortisol levels, and enhancing neurotransmitter balance and can provide adjunctive effects with conventional treatments. Despite these promising findings, the field faces with significant challenges, most notably the absence of standardized manufacturing protocols and the need for more long-term randomized controlled trials to establish efficacy across populations. In addition, regulatory and quality-control frameworks for POSs are being developed, indicating the need for concerted efforts among researchers, health practitioners, and policymakers. As research on supplement formulations continues, as well as the application of functional foods and personalized approaches to nutrition, POSs will be well placed to support expanded therapeutic offerings for psychiatric illnesses and move toward an integrated strategy for mental health.

Authors

Institutions

Publication Details

Journal
Food Hydrocolloids for Health
Published
2026-04-21
DOI
https://doi.org/10.1016/j.fhfh.2026.100279
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Postbiotic Interventions via Hydrocolloid-Enhanced Delivery for Modulating the Gut-Brain Axis in Psychiatric Disorders: A Dietary Strategy Review

Seid Mahdi Jafari, Alireza Zibaei, Alireza Masoumi
Food Hydrocolloids for Health
Gut microbiota and health
article

Postbiotic Interventions via Hydrocolloid-Enhanced Delivery for Modulating the Gut-Brain Axis in Psychiatric Disorders: A Dietary Strategy Review

Seid Mahdi Jafari, Alireza Zibaei, Alireza Masoumi
article en

Abstract

There is increasing evidence that the gut-brain axis (GBAx)—the bidirectional communication network connecting the gastrointestinal tract and the central nervous system—is a vital component of mental health. Historically, probiotics and prebiotics have been recognized for their ability to restore microbial balance, but postbiotics (POS)—comprising non-viable microbial cells or their metabolic by-products are now being more closely examined as a more stable and safer alternative for utilization in research and therapy settings. Hydrocolloid encapsulation emerges as a dietary strategy for stable POS delivery. This review consolidates the current understanding of POS interventions in the regulation of crucial components of GBAx, such as neuroinflammation, neurotransmitter synthesis, immune system, and epigenetic processes; all of which are pertinent to various psychiatric disorders e.g, depression, anxiety, autism spectrum disorder, bipolar disorder, and schizophrenia. Clinical trials have demonstrated that POSs can diminish symptom severity by regulating the immune pathways, balancing cortisol levels, and enhancing neurotransmitter balance and can provide adjunctive effects with conventional treatments. Despite these promising findings, the field faces with significant challenges, most notably the absence of standardized manufacturing protocols and the need for more long-term randomized controlled trials to establish efficacy across populations. In addition, regulatory and quality-control frameworks for POSs are being developed, indicating the need for concerted efforts among researchers, health practitioners, and policymakers. As research on supplement formulations continues, as well as the application of functional foods and personalized approaches to nutrition, POSs will be well placed to support expanded therapeutic offerings for psychiatric illnesses and move toward an integrated strategy for mental health.

Food Hydrocolloids for HealthVol. 9
Mashhad University of Medical Sciences (IR), Islamic Azad University, Mashhad (IR), Ministry of Health and Medical Education (IR), Gorgan University of Agricultural Sciences and Natural Resources (IR)
Zero hunger
Openalex Percentile: Top 12%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.